Contact Us  |  Site Map  |  Search  |  Client Login  
 
 
Boston Millennia Partners
   
  Boston Millennia Partners provides private equity financing to high growth companies in the healthcare and life sciences industry. Our team brings over one hundred years of combined private equity experience to the investment process. Our broad experience, combined with expertise in finance; operations; engineering; life sciences research and development; partnering with pharmaceutical companies; business development; executive recruiting; and law provides significant value to the companies in which we invest. Since the early 1980’s, members of our team have managed seven venture capital partnerships with very successful results for our investors and our entrepreneurs. The growth and success of our portfolio companies have, in turn, allowed us to grow and expand our capital base to over $700 million under management.  
 

Boston Millennia Partners is pleased to announce that its portfolio company, Odyssey Logistics & Technology Corporation, a leading global logistics provider, has achieved revenue growth in excess of 66% in 2011. Benefiting from solid organic growth as well as successfully integrating four recent acquisitions from April 2010 through January 2011, the Company is continuing its acquisition program in 2012. "Odyssey is benefiting from scale, as its larger transportation network enables it to lower costs to its customers. Also,” says Martin Hernon, a partner at Boston Millennia Partners and member of the Odyssey Board of Directors, “the company is an attractive acquisition partner for business owners, as Odyssey management strives to maintain a very fair and congenial culture for the companies that it acquires." Click Here to Read More


 
   
   

Millennia Portfolio Company, PreCision Dermatology Acquires Assets of Triax Pharmaceuticals
Millennia Portfolio Company, PreCision Dermatology, announced the acquisition of the assets of Triax Pharmaceuticals LLC. Triax markets a range of branded prescription dermatology products, including a leading topical steroid, Locoid®, and the acne treatments Minocin® and Tretin X™.



Learn More >

Millennia Portfolio Company, MedAptus, Partners with Intelligent Medical Objects® in Preparation for ICD-10
MedAptus®, the market leader for charge capture technologies, today announced that it has selected Intelligent Medical Objects' IMO® Problem (IT)™ search engine for integration in its Professional Charge Capture solution.

Learn More >

Millennia Portfolio Company, Odyssey Logistics & Technology, Acquires Interdom Partners
Millennia Portfolio Company, Odyssey Logistics & Technology, has acquired a leading U.S. logistics provider, Interdom Partners. Millennia Partners invested in Odyssey's $20 million equity round which enabled this acquisition.

Learn More >

Millennia Portfolio Company, MedAptus, is Selected by Watson Clinic LLC to Improve Revenue Cycle Performance
Millennia Portfolio Company, MedAptus®, today announced that Florida's Watson Clinic LLP has chosen the company's Professional Intelligent Charge Capture solution for its 294 multi-specialty providers to automate the organization's professional charge capture and management activities.



Learn More >

Millennia Portfolio Company, MedAptus, Launches New Revenue Cycle Reporting and Performance Analytics Module
Millennia Portfolio Company, MedAptus®, the market leader for charge capture technologies, announced that its flagship Professional Intelligent Charge Capture solution has been expanded to include a sophisticated reporting and performance analytics package.

Learn More >

Millennia Portfolio Company, Collegium Pharmaceutical Announces Series B Financing and Advancement of Development Program for its DETERx®
Boston Millennia portfolio company, Collegium Pharmaceutical, announced today they have completed a Series B financing which will support the execution of the Company’s full development of a tamper-resistant, extended-release oxycodone product utilizing its proprietary DETERx® technology.

Learn More >

MedAptus First Again in KLAS Mobile Data Systems Rankings
Boston Millennia portfolio company, MedAptus, was named first in KLAS Mobile Data Systems Rankings. MedAptus' top-ranking score in the "2011 Best in KLAS Awards: Software & Services" report is based on positive customer feedback for the second year in a row.

Learn More >

me2me AG and MedAptus Partner to Provide Advanced Mobile Charge Capture, Dictation and Workflow Solutions to Physician Groups
Boston Millennia portfolio company, MedAptus, has partnered with me2me AG, a software company delivering mobile dictation, transcription and speech recognition solutions.

Learn More >

Parexel International Releases 2011 Annual Report
Boston Millennia's Strategic Partner, Parexel International, released their 2011 Annual Report detailing favorable progress over the year.

Learn More >

Dana Callow Elected to National Board of Directors of the Leukemia & Lymphoma Society
Boston Millennia Partners Managing General Partner, Dana Callow, was elected to the Board of Directors of the Leukemia & Lymphoma Society. LLS is the largest voluntary health agency dedicated to blood cancer.

Learn More >

 
 
Click Here to receive news updates
from Boston Millennia Partners >



 
CEO Video Dana Callow on Bloomberg TV with Pimm Fox

Video: Click Here to View
CEO Video NECN CEO Corner Interview With Dana Callow

Video: Large | Small
CEO Video Dana Callow on PBS’s Greater Boston With Emily Rooney

Video: Large | Small
spacer
   
Healthcare information is becoming broadly available to consumers, which is expanding basic demand.
Learn More >
 
   
Three key areas of opportunity in the Life Sciences sector are drug discovery & development...
Learn More >
 
 
  | Our Firm      Our Team      Our Portfolio      Resources      News  
  © 2008 Boston Millennia Partners  All Rights Reserved